Early first episode of pouchitis after ileal pouch–anal anastomosis for pediatric ulcerative colitis is a risk factor for development of chronic pouchitis
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Nov 2018 · 1 min read
In brief
In brief
Retrospective study of 52 pediatric UC patients identifies early pouchitis onset (within 15 months post-IPAA) and preoperative immunomodulator use as key predictors of chronic pouchitis development. Findings suggest enhanced surveillance protocols for high-risk patients may improve long-term pouch outcomes.
Written by the GCMD Library team from the article.
Background
The predictive factors for chronic pouchitis after ileal pouch–anal anastomosis (IPAA) in pediatric-onset ulcerative colitis (UC) remain unclear. This study evaluated the predictive factors for chronic pouchitis after IPAA in patients with pediatric UC.
Methods
The data from 52 patients with pediatric-onset UC who underwent IPAA in Mie University Hospital were retrospectively reviewed. The endoscopy surveillance was performed yearly or at the timing of the symptom. Chronic pouchitis was defined as antibiotic-dependent/-refractory and relapsing cases. Potential predictors of chronic pouchitis were analyzed.
Results
During the first 5 years after IPAA, pouchitis was identified in 32.7%. Of these patients, 12 (70.6%) developed chronic pouchitis. The predictor of chronic pouchitis was a preoperative history of immunomodulator use before IPAA (p = 0.04). Life table analysis revealed that patients with chronic pouchitis tended to develop pouchitis earlier after IPAA than did patients without chronic pouchitis (p = 0.012). Receiver operating characteristic curve analysis showed that the occurrence of pouchitis within 15 months after IPAA surgery predicted the development of chronic pouchitis (sensitivity, 92%; specificity, 80%).
Conclusion
In pediatric patients with UC, the predictive factors for chronic pouchitis are immunomodulator use and early occurrence of the first episode of pouchitis within 15 months after IPAA.
Level of evidence
III